Bell Eve Treatment Center

About Bell Eve Treatment Center

Sublocade treatment at Belleve Treatment Center provides a modern, medically advanced approach to managing opioid use disorder. Sublocade is an FDA-approved extended-release injectable form of buprenorphine that offers continuous medication delivery for up to one month per dose, reducing daily pill burden and supporting consistent recovery.
Our Sublocade program begins with a thorough medical assessment to determine eligibility and suitability, followed by carefully supervised injections administered by trained professionals. Patients receive counseling, education, and support services designed to complement medication therapy and strengthen long-term stability.
Sublocade’s extended-release mechanism helps patients remain focused on life goals rather than daily dosing, offering greater convenience and improved adherence. Belleve’s holistic approach also emphasizes behavioral support, relapse prevention planning, and ongoing health monitoring to maximize treatment success.
Whether a patient is transitioning from traditional sublingual medication or beginning treatment, Sublocade provides a reliable option for sustained opioid dependence management.